Eisai
4523.T
#2112
Rank
A$12.69 B
Marketcap
A$45.04
Share price
0.79%
Change (1 day)
-0.89%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.26. an increase over its 2024 EPS that were of A$1.42.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025A$1.5911.85%
2024A$1.42-32.63%
2023A$2.115.52%
2022A$2.00-74.01%
2021A$7.69-66.58%
2020A$23.0198.24%
2019A$11.6117.01%
2018A$9.9237.78%
2017A$7.20-27.62%
2016A$9.9535.33%
2015A$7.35-2.82%
2014A$7.56-27.66%
2013A$10.46-27.49%
2012A$14.42-12.67%
2011A$16.5188.08%
2010A$8.78-11.06%
2009A$9.87-390.15%
2008A-$3.40-127.78%
2007A$12.2511.78%
2006A$10.964.38%
2005A$10.507.4%
2004A$9.7843.03%
2003A$6.8325.09%
2002A$5.4652.67%
2001A$3.5869.76%
2000A$2.11